Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients

Chen,Xiaochi; Wang,Tiezheng; Yang,Deyong; Wang,Jianbo; Li,Xiancheng; He,Zhongzhou; Chen,Feng; Che,Xiangyu; Song,Xishuang

doi:10.3892/ol.2013.1150

Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients

Authors:
- Xiaochi Chen
- Tiezheng Wang
- Deyong Yang
- Jianbo Wang
- Xiancheng Li
- Zhongzhou He
- Feng Chen
- Xiangyu Che
- Xishuang Song
View Affiliations

Affiliations: Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China
Published online on: January 23, 2013 https://doi.org/10.3892/ol.2013.1150
Pages: 1278-1284

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The inhibitors of apoptosis (IAPs) are a group of anti-apoptotic factors in the apoptotic pathway that render cancer cells insensitive to apoptotic stimulation. Recently, several members of the IAP family have been investigated in the context of bladder cancer, and some of these have been associated with specific clinical and pathological tumor features, and with prognosis. These data suggested that the expression of an individual nuclear IAP has an important relationship with the progression of bladder cancer. To date, there are no studies concerning the overall tendencies of IAPs and their comparative therapeutic values in bladder cancer. In this study, we investigated the overall expression trends of the five tumor-related proteins, Survivin, cIAP1, cIAP2, XIAP and Livin, in normal bladder tissues and bladder cancer tissues. We classified and compared the gene expression data of these IAPs with the corresponding clinical and pathological tumor features, and with prognosis, in the development and progression of bladder cancer. The differences in IAP expression levels between archival bladder specimens from 36 normal controls and 105 patients who underwent surgery at our facility were examined using western blot analysis. The localization and expression level of each protein in low- and high-grade bladder cancer tissues were examined through immunohistochemistry. The cytoplasmic expression levels of each protein were scored as 0 (negative), +1 (weak), +2 (medium) or +3 (strong). The nuclear expression levels of cIAP1 and Survivin were scored as 0 (0%), +1 (1-25%), +2 (26-50%) or +3 (>50%). The results demonstrated that the expression of IAPs acted cooperatively to predict prognosis in human bladder cancer patients.

View Figures

View References

1	Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 49:466–475. 2006. View Article : Google Scholar
2	Vaux DL and Silke J: Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun. 304:499–504. 2003. View Article : Google Scholar : PubMed/NCBI
3	Wei Y, Fan T and Yu M: Inhibitor of apoptosis proteins and apoptosis. Acta Biochim Biophys Sin (Shanghai). 40:278–288. 2008. View Article : Google Scholar : PubMed/NCBI
4	Srinivasula SM and Ashwell JD: IAPs: what’s in a name? Mol Cell. 30:123–135. 2008.
5	Dubrez-Daloz L, Dupoux A and Cartier J: IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle. 7:1036–1046. 2008. View Article : Google Scholar : PubMed/NCBI
6	LaCasse EC, Mahoney DJ, Cheung HH, et al: IAP-targeted therapies for cancer. Oncogene. 27:6252–6275. 2008. View Article : Google Scholar : PubMed/NCBI
7	Dohi T, Okada K, Xia F, et al: An IAP-IAP complex inhibits apoptosis. J Biol Chem. 279:34087–34090. 2004. View Article : Google Scholar : PubMed/NCBI
8	Cheung HH, Plenchette S, Kern CJ, et al: The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways. Mol Biol Cell. 19:2729–2740. 2008. View Article : Google Scholar : PubMed/NCBI
9	Conze DB, Albert L, Ferrick DA, et al: Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol. 25:3348–3356. 2005. View Article : Google Scholar : PubMed/NCBI
10	Vucic D and Fairbrother WJ: The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res. 13:5995–6000. 2007. View Article : Google Scholar : PubMed/NCBI
11	Che X, Yang D, Zong H, et al: Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients. Urol Oncol. 30:450–456. 2012. View Article : Google Scholar : PubMed/NCBI
12	Gazzaniga P, Gradilone A, Giuliani L, et al: Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol. 14:85–90. 2003. View Article : Google Scholar
13	Li M, Song T, Yin ZF, et al: XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin Med J. 120:469–473. 2007.PubMed/NCBI
14	Yin W, Chen N, Zhang Y, et al: Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Mod Pathol. 19:1487–1497. 2006.PubMed/NCBI
15	Mehrotra S, Languino LR, Raskett CM, et al: IAP regulation of metastasis. Cancer Cell. 17:53–64. 2010. View Article : Google Scholar
16	Jin HS, Lee DH, Kim DH, et al: cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-κB activation. Cancer Res. 69:1782–1791. 2009.PubMed/NCBI
17	Yang D, Song X, Zhang J, et al: Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells. Acta Biochim Biophys Sin (Shanghai). 42:137–144. 2010. View Article : Google Scholar : PubMed/NCBI
18	Rodríguez-Berriguete G, Fraile B, de Bethencourt FR, et al: Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. BMC Cancer. 10:182010.
19	Lopes RB, Gangeswaran R, McNeish IA, et al: Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer. 120:2344–2352. 2007. View Article : Google Scholar : PubMed/NCBI
20	Samuel T, Okada K, Hyer M, et al: cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res. 65:210–218. 2005.PubMed/NCBI
21	Stauber RH, Mann W and Knauer SK: Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
22	Amantana A, London CA, Iversen PL and Devi GR: X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther. 3:699–707. 2004.
23	Gill C, Dowling C, O’Neill AJ and Watson RW: Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis. cell survival and proliferation. Mol Cancer. 8:392009. View Article : Google Scholar : PubMed/NCBI
24	Vischioni B, van der Valk P, Span SW, et al: Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol. 37:78–86. 2006. View Article : Google Scholar : PubMed/NCBI
25	Ma L, Huang Y, Song Z, et al: Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ. 13:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
26	Chen F, Yang D, Wang S, et al: Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4. IUBMB Life. 64:274–283. 2012.PubMed/NCBI
27	Xi RC, Biao WS and Gang ZZ: Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie. 34:428–432. 2011. View Article : Google Scholar
28	Li WQ, Li XL, Wang GP and Fu B: Gene expression of livin and survivin in adult patients with acute lymphoblastic leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 19:921–925. 2011.(In Chinese).
29	Peng XH, Karna P, O’Regan RM, et al: Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol. 71:101–111. 2007. View Article : Google Scholar : PubMed/NCBI
30	Choi S, Lew KL, Xiao H, et al: D, L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis. 28:151–162. 2007. View Article : Google Scholar : PubMed/NCBI